Property:Outcome specification
This is a property of type Text.
L
Lua et al. (2015): Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer +
Evaluation of aromatherapy (odor, applicability, treatment effects) +
Lyckholm et al. (2012): A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders +
Change in taste and smell +
M
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Renal toxicity: glomerular filtration rate cc/min (start of the study, day 7 of chemotherapy, day 21 of chemotherapy) +
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Renal toxicity: serum creatinine mg/dL (start of the study, day 7 of chemotherapy, day 21 of chemotherapy) +
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Renal toxicity: urea mg/dL (start of the study, day 7 of chemotherapy, day 21 of chemotherapy) +
Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial +
The patients’ mouths were examined for stomatitis by two assistants on days 1, 3, 5, 7, and 14 with WHO stomatitis intensity survey checklist:
0 = no stomatitis
1 = represents pain and erythema without wounds
2 = refers to the case where wound and erythema exist, but the patient is able to eat solid food
3 = is existence of extensive wound and erythema and inability to eat solid food
4 = mucosal bleeding, extensive inflammation, and complete inability to eat and drink +
Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial +
The patients were asked to report their pain intensity by VAS, a 10cm ruler in which zero shows no pain and 10 represents intolerable pain. +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
NA +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
Oral mucosal erythema +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
Burning Sensation in the mouth +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
Max. degree of mucositis +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
Total daily physical activity and the associated energy expenditure
SenseWear PRO<sub>2</sub> wristband: able to assess total energy expenditure (TEE), that is, the sum of REE plus the energy spent in physical activity (active energy expenditure [AEE]), which is able to identify the specific type of physical activity (e.g., walking, running, lying down) in such a wayastoattribute to it a “functional quality” +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
Lean body mass (LBM) with BIA (all patients); D(E)XA (n=144), CT at L3 (n=25) +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
EORTC QLQC30 and EQ-5D<sub>index</sub>, and EQ-5D<sub>VAS</sub> +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
Multidimensional Fatigue Symptom Inventory - Short Form +